Welcome to the Axis Insights Hub — a central resource for the latest developments, event updates, and expert perspectives on advances in clinical research and analytical methodologies.
Stay up to date with the latest news and events here at Axis and beyond. We will inform you about the current industry news and major activities at Axis, keeping you connected and in the know.
DILWORTH, Minn., Dec. 20, 2024—AXIS Clinicals US is pleased to announce the award of a Radioactive Materials License (RAM License) issued from the Minnesota Department
AXIS Clinicals LLC and Joanneum Research Forschungsgesellschaft mbH are excited to announce the first ever partnership for the clinical applications of dermal open flow microperfusion
DILWORTH, MN, 1st March, 2021 – AXIS Clinicals added another member as part of the consultation team with the welcoming of Dr. Keith Gallicano as the Senior
Our experts share cutting-edge insights, industry trends, and analyses spanning the full spectrum of clinical research, especially focusing on early phase trials.
Browse our comprehensive library of case studies and white papers to learn how we are advancing innovations in drug development
Drug IV Biosimilar Study Design PD and Immunogenicity assessments Multiple sites in EU and US In-house for few days followed by daily/weekly follow up visits
Drug Oral small-molecule prenylation inhibitor treatment of HepD Multiple studies Healthy volunteers equally split by gender Post menopausal women Subject Recruitment Timely recruitment/enrollment for all
Drug Continuous IV Infusion for 24 hr Study Requirements NDA submitted; FDA requested additional TQT study Corporate business target to submit asap Partnered with Clario
